The White House physician allows the president to attend public events starting Saturday; study details long-term coronavirus disease 2019 symptoms in pregnant women; new poll shows record low approval of the pandemic response.
President Donald Trump’s White House physician Sean Conley said the president is able to make a safe return to public events on Saturday, less than 2 weeks after the president tested positive for coronavirus disease 2019 (COVID-19) late on October 1, The Hill reports. According to the CDC, individuals should only resume interactions with others 10 days after symptom onset. Conley said Saturday marks day 10 since the president’s diagnosis and that the president had completed his therapy for COVID-19. As Trump received treatment at Walter Reed National Military Medical Center for 2 days, some health experts question Conley’s assessment, noting some patients with severe COVID-19 symptoms may be infectious for longer than 10 days.
Although most pregnant women with COVID-19 experience a mild form of the disease, many exhibit prolonged symptoms lasting weeks after infection, CIDRAP reports. A new study published in Obstetrics & Gynecology followed nearly 600 pregnant women who tested positive for COVID-19 during pregnancy and reported symptoms at the time of testing. After 3 weeks, 48% of participants were still symptomatic, and symptoms persisted for 8 weeks or longer in 25% of the women. However, 60% of participants reported no symptoms after 4 weeks. Of the 594 women included in the study, 27 were hospitalized and 11 were admitted to intensive care units.
A recent Reuters/Ipsos poll, conducted after the president tested positive for COVID-19, showed just 37% of Americans approve of Trump’s handling of the pandemic, compared with 59% of respondents who disapproved. The net approval rating of –22 percentage points marks the lowest in the poll, which dates back to March 2. Over the last 10 days, approval ratings have steadily declined, coinciding with the president’s diagnosis and return to work in the White House. In comparison, Trump’s rating on pandemic response was –11 percentage points in a previous poll taken from September 30 through October 1.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More